Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
about
Drug-resistant TB: deadly, costly and in need of a vaccineNasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on PneumococciApplication of radiation technology in vaccines developmentInterim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacementPneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world.Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies.Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern IsraelEvolving resistance among Gram-positive pathogensEffect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.Designing malaria vaccines to circumvent antigen variabilityWhy the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant.Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?Nasopharyngeal pneumococcal carriage rates among HIV-infected adults following widespread pediatric use of conjugate pneumococcal vaccine-13.Mechanisms and impact of genetic recombination in the evolution of Streptococcus pneumoniae.Streptococcus pneumoniae serotype 19A: Worldwide epidemiology.First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial.Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive Streptococcus pneumoniae, Switzerland, 2004 to 2014.Colonization with 19F and other pneumococcal conjugate vaccine serotypes in children in St. Louis, Missouri, USA.Pneumococcal Predictive Proteins Selected by Microbial Genomic Approach Are Serotype Cross-Reactive and Bind to Host Extracellular Matrix Proteins.Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.Prevalence of nasopharyngeal pneumococcal colonization in children and antimicrobial susceptibility profiles of carriage isolates.Antibiotic resistance of Streptococcus pneumoniae colonising the nasopharynx of HIV-exposed Tanzanian infants.Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.Macrolide resistance in pneumococci-is it relevant?Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American IndiansReview of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine.Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.Interlaboratory Comparison of the Pneumococcal Multiplex Opsonophagocytic Assays and Their Level of Agreement for Determination of Antibody Function in Pediatric Sera.Effectiveness of the 13-valent pneumococcal conjugate vaccine against adult pneumonia in Italy: a case-control study in a 2-year prospective cohort.
P2860
Q26765385-45FAEB29-6920-4F04-A8C9-3AF1E75D5560Q26782298-C8EDF9A8-B02E-41EE-981C-7CEFF6219E6CQ26798165-4A7DE576-8A52-4845-BA80-C01D711F1A2BQ28069508-352F81C8-5143-4B9C-A135-00F05D342F90Q31157042-A75898F1-BE9C-42F8-937C-A429D0099E5DQ33733347-977E1C4D-958D-406E-BB33-EF79EDCB3E96Q35796784-E39648EC-21F8-4781-A75E-5A1C95856AA8Q35999912-D8FF944F-3D0E-484E-96C3-EC40FE150219Q36283007-9E5AB5DC-85EF-4D6E-BA4C-BC2682C02733Q36514853-A8FE0F03-5BC6-457D-84A7-62E2DC503F40Q37309186-E85A4FA8-87D3-44EE-B0A7-B3A6B6CDBCBFQ37309269-57A0268A-0DCD-46FB-9249-A60EBE7F1D1FQ37357919-C801BEBB-9293-4EF1-9E55-C5505C3C3A1FQ38437227-FC206928-7267-4FF2-A29B-F7D8A23EEE26Q38637072-E2C3EA31-5AA8-4194-ACC6-B27840374F1DQ38950882-0F06967D-3479-4E23-A973-2483CD347DD8Q38956348-6F4D9982-9E77-4BEE-AE78-C6184A497DA2Q39715205-BDF4735F-F15C-4C34-A705-26C787F4BAADQ40131577-3370F2F6-A203-4F36-A307-D6BD49E3A0CDQ40328473-A59D3BE2-0580-443C-9427-4E9BA5863F8AQ40612178-F2D2F7BD-9FBD-49EA-8121-5FBD9A2D5008Q41022197-530FD35F-910C-4F72-B89C-5E18E631C551Q41082335-471083A5-74A0-4653-80E8-E2BD41E07AB6Q41285540-5B5811CA-3761-41C1-A008-9B28F2ADD0C8Q42338498-3C523778-4BAA-4B12-918B-A348AAEE1658Q42419675-0C7795D6-8694-4389-BCAA-8DD8E68777DDQ47429883-98DA1270-F14D-4CCB-B905-1571DB941A8AQ50068226-5E222C5B-9E89-4A1E-B3CD-35AB5D890075Q54939843-66C810DA-7FEE-41C3-BCE9-E7AF2A395680Q55040063-D2FB6344-3D06-41E5-961B-5EFC38F13262
P2860
Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Efficacy of 13-valent pneumoco ...... ible Streptococcus pneumoniae.
@en
type
label
Efficacy of 13-valent pneumoco ...... ible Streptococcus pneumoniae.
@en
prefLabel
Efficacy of 13-valent pneumoco ...... ible Streptococcus pneumoniae.
@en
P2093
P2860
P356
P1476
Efficacy of 13-valent pneumoco ...... ible Streptococcus pneumoniae.
@en
P2093
Alejandra Gurtman
Christine Juergens
Daniel A Scott
David Greenberg
James Trammel
Noga Givon-Lavi
Nurith Porat
Scott Patterson
William C Gruber
P2860
P304
P356
10.1093/INFDIS/JIU576
P407
P577
2014-10-29T00:00:00Z